SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-17-001159
Filing Date
2017-02-27
Accepted
2017-02-27 16:04:25
Documents
81
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_022717p.htm 10-K 1034777
2 EXHIBIT 10.74 exh_1074.htm EX-10.74 494
3 EXHIBIT 10.77 exh_1077.htm EX-10.77 1804
4 EXHIBIT 21 exh_21.htm EX-21 2285
5 EXHIBIT 23 exh_23.htm EX-23 11398
6 EXHIBIT 31.1 exh_311.htm EX-31.1 6925
7 EXHIBIT 31.2 exh_312.htm EX-31.2 6945
8 EXHIBIT 32.1 exh_321.htm EX-32.1 4020
9 EXHIBIT 32.2 exh_322.htm EX-32.2 4149
16 GRAPHIC graph.jpg GRAPHIC 91035
17 GRAPHIC exh1074_1.jpg GRAPHIC 281006
18 GRAPHIC exh1077_1.jpg GRAPHIC 263430
19 GRAPHIC exh1077_2.jpg GRAPHIC 261900
20 GRAPHIC exh1077_3.jpg GRAPHIC 150954
  Complete submission text file 0001171843-17-001159.txt   7741657

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE bcrx-20161231.xml EX-101.INS 1200594
11 XBRL SCHEMA FILE bcrx-20161231.xsd EX-101.SCH 75321
12 XBRL CALCULATION FILE bcrx-20161231_cal.xml EX-101.CAL 60208
13 XBRL DEFINITION FILE bcrx-20161231_def.xml EX-101.DEF 513755
14 XBRL LABEL FILE bcrx-20161231_lab.xml EX-101.LAB 462602
15 XBRL PRESENTATION FILE bcrx-20161231_pre.xml EX-101.PRE 533774
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 17641648
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1